GLP-1 analogs , particularly those like BrightMeds, are increasingly prominence in the treatment of type 2 diabetes and are increasingly explored for obesity . These powerful drugs function to mimicking the body's natural incretin signal , stimulating insulin production and reducing glucagon prod… Read More